Target intelligence / Profile preview

Intestinal mixed micelle (IMM)

Target
IMM
Molecular classification
Other
01

Overview

Intestinal mixed micelles are supramolecular aggregates composed of bile salts, phospholipids, fatty acids, and cholesterol that form in the duodenal lumen during the digestion process [1, 2]. These complexes are essential for the solubilization of hydrophobic cholesterol molecules, enabling their transport across the unstirred water layer to the brush border of enterocytes, where protein transporters such as Niemann-Pick C1-Like 1 (NPC1L1) facilitate their uptake into the cell [3, 4]. By serving as the primary vehicle for both dietary and biliary sterol absorption, these mixed micelles play a pivotal role in maintaining systemic lipid homeostasis and contribute to the development of hypercholesterolemia when cholesterol levels are excessive [5, 10]. Pharmacological intervention often targets the physical and chemical properties of these micelles to reduce systemic cholesterol levels. Plant sterols and stanols lower serum cholesterol by competing with cholesterol for incorporation into the micelle core, thereby reducing the quantity of cholesterol available for intestinal absorption [6, 14]. Furthermore, bile acid sequestrants act by binding to the bile salts necessary for micelle formation, leading to the disruption of the micellar structure and increased fecal excretion of sterols [7, 9]. Understanding and manipulating micellar cholesterol solubility remains a key therapeutic strategy for managing cardiovascular disease and lipid disorders [12, 17].

Other names
Cholesterol micelleMixed micelleDietary mixed micelleBile salt-cholesterol micelleBile acid-lipid micelle
02

Mechanism of action

Competitive displacement of cholesterol from the micellar phase and disruption of micelle formation via sequestration of essential bile acid components

03

Biological functions

Lipid solubilizationCholesterol transportFat-soluble nutrient absorptionLipid homeostasis
04

Disease associations

HypercholesterolemiaCardiovascular diseaseAtherosclerosisDyslipidemia
05

Safety considerations

Fat-soluble vitamin deficiency (A, D, E, K)Gastrointestinal distress (bloating, constipation, or diarrhea)Malabsorption of co-administered lipophilic medicationsIncreased fecal fat excretion
06

Interacting drugs

Sitosterol

5 more in the full profile.

07

Biomarkers

Serum LDL-cholesterol levelsFecal sterol excretionMicellar cholesterol solubility (experimental)Plasma plant sterol-to-cholesterol ratio

Beyond the preview

Go deeper on Intestinal mixed micelle (IMM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal mixed micelle (IMM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call